AEON Biopharma enters underwriting agreement for stock sale
AEON Biopharma entered into an underwriting agreement with Lake Street Capital Markets to sell 17.85 million shares of Common Stock and related warrants. This planned financing will provide immediate liquidity to support the company's business development and operational needs.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day